Connection

Giuliano Rizzardini to Antiretroviral Therapy, Highly Active

Back to Details
This is a "connection" page, showing publications Giuliano Rizzardini has written about Antiretroviral Therapy, Highly Active.
Giuliano Rizzardini
Connection Strength
0.967
Antiretroviral Therapy, Highly Active
  1. Does simplification to dolutegravir-based dual regimens impact on the CD4+/CD8+ T-cell ratio? AIDS. 2018 05 15; 32(8):1083-1084.
    View in: PubMed
    Score: 0.479
  2. Antiretroviral treatments' durability and costs: important elements in the choice of first-line therapy. AIDS. 2016 09 10; 30(14):2247-9.
    View in: PubMed
    Score: 0.426
  3. Impact of prolonged maraviroc treatment on non-AIDS-related comorbidities in HIV-positive patients: a retrospective cohort study. J Antimicrob Chemother. 2019 09 01; 74(9):2723-2731.
    View in: PubMed
    Score: 0.033
  4. Brief Report: Drop in CD4+ Counts Below 200 Cells/µL After Reaching (or Starting From) Values Higher than 350 Cells/µL in HIV-Infected Patients With Virological Suppression. J Acquir Immune Defic Syndr. 2017 12 01; 76(4):417-422.
    View in: PubMed
    Score: 0.029
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.